medtronic
-
Medtronic spinal treatment gets second approval from FDA
Medtronic Inc. has received a second clearance from the Food and Drug Administration for its TSRH Spinal System, which is designed…
Read More » -
Financial
Medtronic Completes Acquisitions of PEAK Surgical, Inc. and Salient Surgical Technologies, Inc.
MINNEAPOLIS – August 31, 2011 – Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of two privately-held…
Read More » -
Medtronic Profit Slips 1 Percent
Medtronic Inc. saw its fiscal first-quarter earnings slip, bringing the world’s largest medical device maker to 77 cents per share.…
Read More » -
Medtronic Reports First Quarter Earnings
MINNEAPOLIS, Aug 23, 2011 (BUSINESS WIRE) — Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of…
Read More » -
Spine
Medtronic investors look for new CEO’s plan
CHICAGO (Reuters) – Medtronic Inc’s new chief executive, Omar Ishrak, will be pressed for details on his plan to revive…
Read More » -
Hospitals
IOM Calls 510(k) Process “Flawed”, Recommends FDA Develop New System
The long-awaited IOM report on the 510(k) framework was released this morning, and, not unexpectedly, the IOM found flaws in the system.…
Read More » -
Financial
Medtronic spends $585M to buy two companies
Medtronic Inc. said Thursday it spent $585 million to buy two companies in which it had already invested. Fridley-based Medtronic…
Read More » -
Medtronic deals with questions of biased research
In a strong course of action, The Spine Journal recently dedicated its entire June issue to a review of recombinant…
Read More » -
Spine
Infuse Furor May Force Medtronic Spine Business Sale. Who Would Buy?
A Wall Street analyst is speculating that Medtronic‘s (NYSE:MDT ) woes over its blockbuster Infuse product might lead the medical device company…
Read More » -
Biologics
Spine Experts Repudiate Medtronic Studies
In an extraordinary move, a group of spine specialists are publicly repudiating the research of other experts that has backed…
Read More » -
Biologics
Medtronic’s Infuse Off-Label, Doctor Payment Woes; Senate Probe
Medtronic is in trouble regarding its Infuse spine surgery product which was approved by the FDA in 2009 but has…
Read More » -
Spine
U.S. Senate panel probes Medtronic
A U.S. Senate committee has launched an investigation into reports that doctors with financial ties to the medical device company…
Read More » -
Spine
Official Senate Letter to Medtronic
http://media.jsonline.com/documents/Medtronic_Infuse_6_21_2011.pdf June 21, 2011Via Electronic TransmissionOmar Ishrak, Ph.D.Chairman and Chief Executive OfficerMedtronic, Inc.710 Medtronic ParkwayMinneapolis, MN 55432Dear Dr. Ishrak:The United…
Read More » -
Medtronic spokesman: State report in error, company has already completed local layoffs
Medtronic Inc. has already completed its reduction in force, according to a company spokesman, and will not lay off any…
Read More »